Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Immunisation, Inflammation, Musculoskeletal disorder, Neuritis
Clinical narrative: Booster; Severe inflammation of the arm foe over ten days with pain sufficiently high to prevent sleep or use of the arm; Severe inflammation of the arm foe over ten days with pain sufficiently high to prevent sleep or use of the arm/   had the shot was totally in pain; Severe inflammation of the arm foe over ten days with pain sufficiently high to prevent sleep or use of the arm; Severe inflammation of the arm foe over ten days with pain sufficiently high to prevent sleep or use of the arm; like burning fire/ burning feeling from shoulder to the tip of my fingers and arms; inflammation of the nerves; This is a spontaneous report received from a contactable reporter(s) (Pharmacist). The reporter is the patient.  A 82 year-old female patient (not pregnant) received bnt162b2 (BNT162B2, Solution for injection), intramuscular, administered in arm left, administration date 08Sep2021 14:00 (Lot number: 301308A) at the age of 82 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "diabetes" (unspecified if ongoing); "thyroid" (unspecified if ongoing); "cholesterol" (unspecified if ongoing); "high blood pressure" (unspecified if ongoing). Concomitant medication(s) included: METFORMIN taken for diabetes mellitus (ongoing); JANUVIA taken for diabetes mellitus (ongoing); COZAAR taken for blood pressure measurement; PRAVASTATIN taken for blood cholesterol (ongoing); LEVOTHYROXINE taken for thyroid disorder (ongoing); LOSARTAN [LOSARTAN POTASSIUM] taken for hypertension (ongoing). Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Time(24hr): 02:30 pm, Anatomical Site of injection: BHSF, Route of administration: Intramuscular, Batch/Lot number: Pfizer EL9231), administration date: 12Jan2021, when the patient was 81 years old, for COVID-19 Immunization, reaction(s): "Left arm where I had the shot was totally in pain", "burning feeling from shoulder to the top of my fingers", "I couldn't sleep day or night", "inflammation of the nerves in my arm"; Bnt162b2 (Dose 2, SINGLE, Time(24hr): 01:30 pm, Anatomical Site of injection: BHSF, Route of administration: Intramuscular, Batch/Lot number: Pfizer EL8982), administration date: 04Feb2021, when the patient was 82 years old, for COVID-19 Immunization, reaction(s): "chills", "body pains", "like flu". The following information was reported: INFLAMMATION (non-serious), SLEEP DISORDER (non-serious), MUSCULOSKELETAL DISORDER (non-serious) all with onset 08Sep2021, outcome "not recovered" and all described as "Severe inflammation of the arm foe over ten days with pain sufficiently high to prevent sleep or use of the arm"; PAIN IN EXTREMITY (non-serious) with onset 08Sep2021, outcome "recovered" (2021), described as "Severe inflammation of the arm foe over ten days with pain sufficiently high to prevent sleep or use of the arm/   had the shot was totally in pain"; BURNING SENSATION (non-serious) with onset 08Sep2021, outcome "not recovered", described as "like burning fire/ burning feeling from shoulder to the tip of my fingers and arms"; NEURITIS (non-serious) with onset 08Sep2021, outcome "recovering", described as "inflammation of the nerves"; IMMUNISATION (non-serious) with onset 08Sep2021 14:00, outcome "unknown", described as "Booster". The events "severe inflammation of the arm foe over ten days with pain sufficiently high to prevent sleep or use of the arm", "severe inflammation of the arm foe over ten days with pain sufficiently high to prevent sleep or use of the arm/   had the shot was totally in pain", "severe inflammation of the arm foe over ten days with pain sufficiently high to prevent sleep or use of the arm", "severe inflammation of the arm foe over ten days with pain sufficiently high to prevent sleep or use of the arm", "like burning fire/ burning feeling from shoulder to the tip of my fingers and arms" and "inflammation of the nerves" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of inflammation, sleep disorder, musculoskeletal disorder. Therapeutic measures were taken as a result of pain in extremity, burning sensation, neuritis.  Additional Information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.   Follow-up attempts are completed. No further information is expected.